查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1138027

3D 醫療和外科成像平台市場 - 增長、趨勢、COVID-19 影響和預測（2022-2027 年）

3D Medical and Surgical Imaging Platform Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，3D 醫療和手術成像平台市場預計將以 18% 的複合年增長率增長。

此外，市場上平台提供商對醫療保健 IT 的各種創新解決方案和投資等某些因素正在推動 3D 醫療和手術成像平台市場。

主要亮點

  • 由於其在心臟病學和腫瘤學中的廣泛使用，3D 醫學成像的需求量很大。例如，心臟瓣膜置換術是心髒病學中最常見的手術之一。經導管主動脈瓣置換術被認為是微創心臟瓣膜置換術之一。新心臟瓣膜的定位是外科醫生非常關心的問題。外科醫生更喜歡使用 3D 血管造影成像軟件在放置新心臟瓣膜期間查看解剖結構，因為新心臟瓣膜的定位可能很關鍵。
  • 此外，2021 年 5 月，英格蘭國民健康服務 (NHS) 推出了一項名為“HeartFlow”的專有技術，用於快速檢測和治療疑似心髒病。根據 NHS 長期計劃提供的 HeartFlow 據說可以將正常的心臟計算機斷層掃描 (CT) 掃描轉換為三維 (3D) 圖像，從而能夠在 20 分鐘內檢測出冠心病，並有望成為市場領先，進一步推動增長。
  • 由於現代可視化技術和技術平台的快速發展，以及慢性病診斷和監測中對 3D 成像的需求不斷增長，市場正在擴大。此外，向微創手術的轉變和混合手術室的增加也推動了市場的發展。
  • 此外，2021 年 12 月，WEHI（Walter and Eliza Hall Institute of Medical Research）的研究人員將開發一種新方法來模擬乳腺癌細胞如何侵入和擴散骨骼、重塑自身以促進腫瘤生長，並開發增強型 3D 成像技術。該研究可以指導為患有通常應用於骨骼的癌症（如乳腺癌和前列腺癌）的患者開發新的治療方法。
  • 創新圖像處理技術的快速發展正在為研究目標市場的增長鋪平道路。例如，2021 年 2 月，由 UMass Lowell 領導的一個研究小組宣布了一種新的 3D 成像技術，用於檢測乳腺癌和其他疾病，包括 COVID-19。這種非侵入性醫療技術採用專門的對比增強染料來識別乳腺癌細胞，使從業者能夠更好地觀察體內的人體組織。這種染料與稱為“光子計數光譜 CT”的計算機斷層掃描 (CT) 掃描儀相結合，可放大腫瘤的 X 射線信號並產生多色 3D 圖像。研究人員聲稱，將這種造影劑與光譜 CT 和機器學習相結合將導致更準確的疾病診斷，這將大大有助於早期干預。
  • 此外，COVID-19 大流行直接和間接導致 2020 年和 2021 年上半年經合組織國家的死亡人數估計增加了 16%。30 個國家中的 24 個國家的預期壽命有所下降，大流行對心理健康產生了重大影響。大流行還導致經合組織的醫療保健支出大幅增加。

主要市場趨勢

雲有望實現顯著增長

  • 雲計算為醫學影像帶來了原始數據管理的競爭優勢。根據醫療影像解決方案的類型和行業發展水平，雲計算將應用於雲影像歸檔、海量影像數據存儲、遠程醫療影像災備、3D醫療影像應用、移動雲影像等多種場景。還提供圖像讀取、圖像中心等基於軟件的應用程序。
  • 企業成像系統和 PACS（圖片存檔和通信系統）正在轉向基於雲的解決方案，因為它們可以解決各種醫院問題。基於雲的系統還有助於與大型醫院電子病歷 (EMR) 系統集成。
  • 此外，醫院和其他醫療機構可以通過利用基於雲的解決方案最大限度地減少對 IT 基礎設施的投資。這意味著可以通過自動化一些重複性的管理任務來降低勞動力成本。因此，雲提供了很大的可擴展性，使醫生能夠專注於他們的病人，而不是他們的 IT 擔憂。
  • 此外，2021 年 8 月，GE Healthcare 宣布了其名為 Edison True PACS 的下一代基於雲的圖片存檔和通信系統 (PACS)。新的基於雲的成像和工作流程解決方案支持面臨越來越高的員工倦怠和退休率的放射科醫生，使他們能夠更準確、更高效地工作，同時控制資本和 IT 資源旨在此外，新解決方案為放射科醫生提供了人工智能決策支持，以適應更高的工作量、增加檢查的複雜性並提高診斷準確性。

北美預計將佔據重要份額

  • 由於手術數量的增加、慢性病患病率的增加以及該地區醫院越來越多地採用混合手術室，預計北美將佔據市場的重要份額。
  • 該地區的 3D 成像研究和開發正在取得進展，自動化 3D 成像掃描儀的數量不斷增加。例如，2022 年 7 月，SMARTTECH 擴展了其 3D 掃描儀配件系列。SMARTTECH 配件系列中新增的 Professional FOBA Stand 擴展了 SMARTTECH 3D 掃描儀的人體工程學使用可能性。
  • 由於醫院、長期護理中心和高度專業化中心等醫療環境的購買力不斷增強，該地區的市場正在顯著增長。此外，與發展中地區相比，有利的報銷方案和完善的醫療基礎設施預計將對預測期內該地區的增長產生積極影響。
  • 醫療保健行業自動化程度的提高以及慢性病診斷和監測中對 3D 成像的需求不斷增長等因素預計將豐富多家醫療保健公司進入該地區的機會。
  • 此外，2022 年 1 月，Francisco Partners 將加入 IBM（美國）和 IBM 的投資組合公司，包括 Health Insights、MarketScan、Clinical Development、Social Program Management、Micromedex 和 Imaging Software Offerings，現在是 Watson Health 業務的一部分。開發醫療保健數據和分析資產的協議

競爭格局

由於少數主要參與者進入市場，3D 醫療和手術成像平台市場正在整合。市場參與者專注於研發，以開發技術先進的產品並降低與其產品相關的成本和副作用。該行業的參與者不斷努力改進他們的產品組合，以通過併購、合作夥伴關係和不斷創新來獲得競爭優勢。

  • 2022 年 6 月——Trivitron Healthcare 計劃在 2022-23 年推出印度製造的 CT 掃描和 MRI。由於其智能功能、低成本和便攜性，它將在印度和國際市場上用於更好的診斷。它還將在印度孟買的 Patalganga 工業區開設第二家超聲波製造工廠。
  • 2021 年 11 月 - 健康技術的全球參與者ROYAL PHILIPS宣佈在北美放射學會推出新的 AI 支持的 MR 成像創新。PHILIPS新的 MR 智能集成解決方案組合旨在幫助您加快 MR 檢查、簡化工作流程、優化診斷質量並確保放射學操作的效率和可持續性。

其他福利

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第 1 章 簡介

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第三章執行摘要

第四章市場洞察

  • 市場概況
  • 行業吸引力——波特五力分析
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭對手之間的競爭
  • 行業價值鏈分析
  • COVID-19 的市場影響評估

第五章市場動態

  • 市場驅動力
    • 慢性病診斷和監測中對 3D 成像的需求不斷增長
    • 醫療保健支出增加
    • 開發最新的可視化方法和技術基礎
  • 市場挑戰
    • 設備初始成本高

第六章市場細分

  • 通過部署
    • 本地
    • 雲
  • 按組件
    • 硬件
    • 軟件和解決方案
  • 按申請
    • CT掃描
    • 核磁共振
    • 超聲診斷
    • 神經影像學
    • 脊柱成像
    • 其他應用
  • 區域信息
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲

第 7 章 競爭格局

  • 公司簡介
    • Ambra Health Inc.
    • Arterys Inc.
    • Brainlab AG
    • Depuy Synthes Inc.
    • Medtronic Inc.
    • Kitware Inc.
    • Mach7 Technologies Ltd
    • NDS Surgical Imaging LLC
    • Olympus Corporation
    • NerveVision Inc.
    • Siemens Healthcare Pvt. Ltd
    • Pie Medical Imaging BV
    • Quibim SI

第八章投資分析

第九章 市場潛力

簡介目錄
Product Code: 66970

The 3D Medical and Surgical Imaging Platform Market is expected to register a CAGR of 18% over the forecast period. Certain factors, such as the various inventive resolutions from platform providers in the market and investments in healthcare IT, are also liable for driving the 3D medical and surgical imaging platform market.

Key Highlights

  • There is an increased demand for 3D medical imaging due to its vast applications in cardiology and oncology. For instance, Heart valve replacement is one of the most common procedures in cardiology. Transcatheter aortic valve replacement is considered one minimally invasive heart valve replacement procedure. Positioning the new heart valve is a severe concern to surgeons. Surgeons prefer 3D angiography imaging software to view the anatomy during the placement of heart valves, as positioning a new heart valve seems crucial.
  • Additionally, in May 2021, the National Health Service England (NHS) unveiled a unique technology called HeartFlow to detect and treat people with suspected heart disease quickly. Delivered under the NHS Long Term Plan, HeartFlow is claimed to convert a regular computed tomography (CT) scan of the heart into a three-dimensional (3D) image to enable the detection of coronary heart disease in 20 minutes, further driving the market growth.
  • Due to the surging development of modern visualization methods and technology platforms, along with rising demand for 3D imaging in diagnosing and monitoring chronic diseases, the market is growing. A shift toward minimally invasive procedures and increasing adoption of hybrid operating rooms also provide traction for the market.
  • Furthermore, in December 2021, WEHI (Walter and Eliza Hall Institute of Medical Research) researchers developed enhanced 3D imaging technology to model how breast cancer cells invade and spread into the bone and remodify themselves to fuel tumor growth. The research could guide the development of new therapies for patients suffering from cancers that are typically applied to the bone, including breast and prostate cancers.
  • The rapid advancements in innovative imagining techniques are paving the way for the growth of the studied market. For instance, in February 2021, a research team led by UMass Lowell introduced a new 3D imaging technique to detect breast cancer and other diseases, including COVID-19. The noninvasive medical technology employs specialized contrasting dye that identifies breast cancer cells, allowing practitioners to visualize human tissue inside the body better. The dye amplifies the X-ray signal in tumors when combined with computed tomography (CT) scanner, called a "photon-counting spectral CT," which produces multi-colored, 3D images. The researchers claimed that the contrast agents, combined with spectral CT and machine learning, could lead to a more precise disease diagnosis and significantly assist in early intervention.
  • Furthermore, the COVID-19 pandemic contributed to a 16% increase in the estimated number of deaths in OECD nations in 2020 and the first half of 2021, both directly and indirectly. Life expectancy has decreased in 24 of the 30 countries, and the pandemic has had a significant mental health impact. In addition, the pandemic has resulted in a substantial surge in healthcare spending across the OECD.​

Key Market Trends

Cloud Expected to Witness Significant Growth

  • Cloud computing gives medical imaging a competitive advantage in raw data management. Depending on the medical imaging solution types and the industry's development level, cloud computing can be utilized in a variety of scenarios, including cloud image archiving, massive image data storage, and remote medical image disaster recovery, as well as cloud image-based software applications such as 3D healthcare image applications, mobile image reading, and imaging centers.
  • The trend for enterprise imaging systems and Picture Archive and Communication systems (PACS) is moving to cloud-based solutions owing to their ability to solve several hospital issues. In addition, cloud-based systems support easier integration with large hospital electronic medical record (EMR) systems.
  • Furthermore, hospitals and other healthcare facilities can minimize their IT infrastructure investment by utilizing cloud-based solutions. That means reducing labor costs through automating several repetitive management tasks. Therefore, the cloud is bringing a lot of scalabilities, and physicians can emphasize patients rather than IT concerns.
  • Further, in August 2021, GE Healthcare introduced a next-generation, cloud-based Picture Archive and Communication System (PACS) called Edison True PACS. This new cloud-based diagnostic imaging and workflow solution is designed to support and enable radiologists facing increased rates of staff burnout and retirements to be more precise and efficient while keeping capital and IT resources under control. Moreover, this new solution offered AI-enabled decision support to help radiologists acclimate to higher workloads, augment exam complexity, and enhance diagnostic accuracy.

North America Expected to Hold Significant Share

  • North America is expected to hold a significant share of the market due to the rising number of surgeries, increasing prevalence of chronic disease, and the growing adoption of the hybrid operating room by hospitals across the region.
  • The region is witnessing an increase in automated 3D imaging scanners, and there is ongoing R&D development for 3D imaging. For instance, in July 2022, SMARTTECH expanded its line of 3D scanner accessories. Adding professional FOBA stands to the SMARTTECH accessory line expands the possibilities for the ergonomic use of SMARTTECH 3D scanners.
  • The market across the region is significantly growing due to the increasing purchasing power of the healthcare settings, such as hospitals, long-term care centers, and advanced specialty centers. Moreover, compared to developing regions coupled with a favorable reimbursement scenario, a well-established healthcare infrastructure is anticipated to bode well for regional growth during the forecast period.
  • Factors such as the growing adoption of automation in the healthcare sector and escalating demand for 3D imaging in diagnosing and monitoring chronic diseases are expected to provide plenty of opportunities for several healthcare companies to expand across the region.
  • Further, in January 2022, Francisco Partners signed an agreement with IBM (US) to develop healthcare data and analytics assets from IBM, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex, and imaging software offerings, which are currently part of the Watson Health business.

Competitive Landscape

The 3D medical and surgical imaging platform market is consolidated owing to a few major players in the market. The market players are focusing on R&D to develop technologically advanced products to reduce the cost and side effects associated with the products. The players in this industry are continually working on improving their product portfolio to gain competitive advantages with mergers and acquisitions, partnerships, and constant innovations.

  • June 2022 - Trivitron Healthcare plans to launch made-in-India CT-Scan and MRI in 2022-23. Because of its smart features, low cost, and portability will be used for better diagnosis in both the Indian and international markets. In addition, the company intends to open its second ultrasound manufacturing facility in India at Patalganga Industrial Area in Mumbai.
  • November 2021 - Royal Philips, a global player in health technology, announced at the Radiological Society of North America the launch of new AI-enabled innovations in MR imaging. Philips' new MR portfolio of intelligent integrated solutions is intended to speed up MR exams, streamline workflows, optimize diagnostic quality, and help ensure radiology operations' efficiency and sustainability.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porters Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Threat of Substitutes
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of Impact of COVID-19 on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Rising Demand for 3D Imaging in Diagnosing and Monitoring of Chronic Diseases
    • 5.1.2 Rising Healthcare Expenditures
    • 5.1.3 Development of Modern Visualization Methods and Technology Platforms
  • 5.2 Market Challenges
    • 5.2.1 High Initial Costs of Equipment

6 MARKET SEGMENTATION

  • 6.1 By Deployment
    • 6.1.1 On-premise
    • 6.1.2 Cloud
  • 6.2 By Component
    • 6.2.1 Hardware
    • 6.2.2 Software & Solution
  • 6.3 By Application
    • 6.3.1 CT-Scan
    • 6.3.2 MRI
    • 6.3.3 Ultrasound
    • 6.3.4 Neurological Imaging
    • 6.3.5 Spinal Imaging
    • 6.3.6 Other Applications
  • 6.4 By Geography
    • 6.4.1 North America
    • 6.4.2 Europe
    • 6.4.3 Asia Pacific
    • 6.4.4 Latin America
    • 6.4.5 Middle East & Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Ambra Health Inc.
    • 7.1.2 Arterys Inc.
    • 7.1.3 Brainlab AG
    • 7.1.4 Depuy Synthes Inc.
    • 7.1.5 Medtronic Inc.
    • 7.1.6 Kitware Inc.
    • 7.1.7 Mach7 Technologies Ltd
    • 7.1.8 NDS Surgical Imaging LLC
    • 7.1.9 Olympus Corporation
    • 7.1.10 NerveVision Inc.
    • 7.1.11 Siemens Healthcare Pvt. Ltd
    • 7.1.12 Pie Medical Imaging BV
    • 7.1.13 Quibim SI

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET